ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6 | -62.5% | 26,473 | -42.4% | 0.00% | -100.0% |
| Q1 2023 | $16 | -15.8% | 45,994 | -47.4% | 0.00% | -33.3% |
| Q4 2022 | $19 | -99.9% | 87,405 | +12.5% | 0.00% | +50.0% |
| Q3 2022 | $27,000 | -37.2% | 77,694 | +142.7% | 0.00% | -50.0% |
| Q2 2022 | $43,000 | -45.6% | 32,013 | +3.1% | 0.00% | -50.0% |
| Q2 2021 | $79,000 | +88.1% | 31,038 | +64.2% | 0.01% | +14.3% |
| Q3 2020 | $42,000 | – | 18,902 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,817,454 | $3,653,000 | 0.07% |
| CSS LLC/IL | 41,300 | $83,000 | 0.00% |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 35,000 | $70,000 | 0.00% |
| CSS LLC/IL | 33,900 | $68,000 | 0.00% |
| Private Advisor Group, LLC | 34,150 | $69,000 | 0.00% |
| OPPENHEIMER & CO INC | 38,500 | $77,000 | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 590,852 | $1,187,000 | 0.00% |
| UBS Group AG | 6,840 | $14,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,321 | $25,000 | 0.00% |